GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Stock Based Compensation

G.Barekat Pharm (XTEH:BRKT1) Stock Based Compensation : IRR0 Mil (TTM As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Stock Based Compensation?

G.Barekat Pharm's Stock Based Compensation for the six months ended in Mar. 2017 was IRR0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2017 was IRR0 Mil.


G.Barekat Pharm Stock Based Compensation Historical Data

The historical data trend for G.Barekat Pharm's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Stock Based Compensation Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
Stock Based Compensation
- -

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
Stock Based Compensation - -

G.Barekat Pharm Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2017 was IRR0 Mil.


G.Barekat Pharm Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


G.Barekat Pharm (XTEH:BRKT1) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines